$UTMD

Utah Medical sets 31-cent payment for shareholders on Oct. 5

Utah Medical Products (Nasdaq: UTMD) said its board approved a quarterly cash dividend of $0.31 per share payable Oct. 5, 2026 to shareholders of record as of Sept. 17, 2026. The company stated this is a 1.6% increase versus the dividend declared for the same quarter a year earlier.

Original reporting
Published Aug 4, 2026, 2:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 4, 2026, 5:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$UTMD
Bullish
medium confidence
Mentioned
$UTMD
Relevance
5/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$UTMDBullishLow
01

Why it matters

For UTMD, the key tradable elements are the dividend amount ($0.31), the record date (Sept. 17, 2026), and the payment date (Oct. 5, 2026). The disclosure does not include earnings, guidance, or other fundamental changes.

02

Market read

This is a routine dividend declaration with a modest YoY increase, offering limited incremental information for price discovery.

03

What to watch

Traders may focus more on ex-dividend date mechanics and yield relative to peers than on the declaration itself, since no operational catalyst is provided.

Relevance 5/10Novelty 5/10Timing: dividend payable Oct. 5, 2026, with record date Sept. 17, 2026

Background

The company announced a quarterly cash dividend approved by its board, including the record date and payment date.

Company-level read

Ticker impact

$UTMDBullishMedium confidence
Context

Utah Medical Products’ board approved a $0.31 quarterly cash dividend payable Oct. 5, 2026, with a Sept. 17 record date.

Expected impact

Low near-term impact; any reaction is likely limited to dividend-focused flows around the declaration and ex-dividend timing.

Evidence & confidence

The article discloses a routine quarterly dividend and a small 1.6% YoY increase, with no guidance, earnings, or balance-sheet change.

Market effects

Limited read-through to medical device peers; dividend announcements are typically company-specific.

Minimal, as this is a single-company corporate action.

Low, no cross-border deal, regulation, or supply-chain event mentioned.

Counterpoint

The dividend increase is small (1.6% YoY), so it may not offset any underlying concerns about growth or margins.

Key entities

  • Utah Medical Products, Inc.

    Nasdaq-listed medical device company that approved a quarterly cash dividend of $0.31 per share.

  • Board of Directors

    Approved the quarterly cash dividend and set the record and payment dates.

Related articles

$UTMDHigh

UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2026

UTAH MEDICAL PRODUCTS INC (UTMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2026 Contact: Brian Koopman (801) 566-1200 October 22, 2026 Salt Lake City, Utah – Utah Medical Products, Inc. [Nasdaq: UTMD] reports third quarter (3Q) and first nine months (9M) of calend

$UTMDHigh

Utah Medical Products, Inc. Commences Tender Offer

Utah Medical Products (UTMD) offers to buy up to 650,000 shares at $75 each, a 17% premium over the 12-month average. The tender offer, approved by the board, aims to provide liquidity. UTMD's H1 2026 sales and profits declined 12% and 13% YoY, with recent EBITDA at $15.7M. CEO Cornwell believes shares are undervalued, citing industry multiples. The offer expires Oct 7 unless extended.

$UTMDMed

UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2026

UTAH MEDICAL PRODUCTS INC (UTMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 utmd_ex99z1.htm EXHIBIT 99.1 EXHIBIT 99.1 UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2026 Contact: Brian Koopman (801) 566-1200 July 23, 2026 Salt Lake City, Utah – Utah Medical Products, Inc. [Nasdaq: UTMD] reports second calendar qua